FDA cracks down on ‘misleading’ compounded GLP-1s by telehealth companies
The FDA is taking action against telehealth companies for allegedly misleading compounded GLP-1 medications. This episode also touches on IMPD assisting families after homicides, a student ID voting ban, Carmel resident feedback on an ICE office, Pakistan hosting peace talks…